A Microchip for High-throughput Axon Growth Drug Screening

Area of Science:

• Neuroscience
• Biomaterials Science
• Regenerative Medicine

Background:

• Mature central nervous system (CNS) axonal regeneration is hindered by inhibitory myelin-associated molecules and intrinsic axonal growth limitations.
• Conventional cell culture methods are inadequate for high-throughput screening of localized drug effects on axon growth.

Purpose of the Study:

• To develop an innovative in vitro tool for high-throughput screening of drugs targeting CNS axonal regeneration.
• To enable localized treatment and assessment of axonal responses to biomolecules.

Main Methods:

• A compartmentalized neuron culture platform was engineered with 24 isolated axon compartments.
• The platform allows simultaneous localized biomolecular treatments and features a microfluidic system for efficient medium replenishment.
• This design facilitates parallelized, high-throughput drug screening.

Main Results:

• The developed platform enables localized biomolecular treatments on axons physically and fluidically isolated from neuronal somata.
• It supports simultaneous testing of multiple conditions across 24 compartments on a single device.
• The microfluidic design streamlines medium exchange, facilitating high-throughput drug screening.

Conclusions:

• The novel compartmentalized neuron culture platform overcomes the limitations of conventional methods for studying axonal regeneration.
• This tool is crucial for accelerating the discovery and development of therapeutic drugs for CNS injury recovery.
• It represents a significant advancement in in vitro screening for promoting axonal growth.